Overview

Study in Advanced Solid Tumors

Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to help answer the following research question(s): - To see how the body absorbs, processes, and gets rid of cetuximab when the drug is taken in combination with cisplatin [pharmacokinetic (PK) analysis] - To see if any drug interactions occur between cetuximab and cisplatin.
Phase:
Phase 2
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Cetuximab
Cisplatin
Fluorouracil